• Publications
  • Influence
Acute liver injury following Garcinia cambogia weight-loss supplementation: case series and literature review
Herbal weight-loss supplements are sold as self-medication products, and are often used under the misconception that their natural origin guarantees their safety. Food supplements are not required toExpand
  • 19
  • 2
Characterization of serious adverse drug reactions as cause of emergency department visit in children: a 5-years active pharmacovigilance study
BackgroundTo describe frequency, preventability and seriousness of adverse drug reactions (ADRs) in children as cause of emergency department (ED) admission and to evaluate the association betweenExpand
  • 10
  • 2
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study
Objective This study was aimed at assessing the long-term ocular control of adalimumab (ADA) in a large real-world population with noninfectious primary or secondary uveitis, focusing on theExpand
  • 7
  • 1
  • Open Access
Behçet’s syndrome as a tool to dissect the mechanisms of thrombo‐inflammation: clinical and pathogenetic aspects
Behçet’s syndrome (BS) is a complex disease with different organ involvement. The vascular one is the most intriguing, considering the existence of a specific group of patients suffering fromExpand
  • 10
  • 1
Treating the Different Phenotypes of Behçet's Syndrome
Behçet's syndrome (BS) is a multisystemic vasculitis, characterized by different clinical involvements, including mucocutaneous, ocular, vascular, neurological, and gastrointestinal manifestations.Expand
  • 4
  • 1
  • Open Access
Vascular Behçet’s syndrome: an update
Behçet’s syndrome (BS) is a complex vasculitis, characterised by peculiar histological, pathogenetic and clinical features. Superficial venous thrombosis (SVT) and deep vein thrombosis (DVT) are theExpand
  • 25
Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study.
OBJECTIVE To evaluate the efficacy and safety of secukinumab in Behçet's patients with active mucocutaneous and articular manifestations refractory to previous treatments. METHODS WeExpand
  • 19
SARS-CoV-2 infection among patients with systemic autoimmune diseases
Abstract Objectives This study aimed to evaluate the prevalence of clinically overt SARS-CoV-2 infection (COVID-19) among patientsExpand
  • 18
Adalimumab‐Based Treatment Versus Disease‐Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome
Since Behçet's syndrome (BS) is the prototype of inflammation‐induced thrombosis, immunosuppressants are recommended in place of anticoagulants. We undertook this study to assess the clinicalExpand
  • 19
The right place of interleukin-1 inhibitors in the treatment of Behçet’s syndrome: a systematic review
Behçet’s syndrome (BS) is a chronic (auto)-inflammatory disorder characterized by different clusters of symptoms, including mucocutaneous and ocular involvements. Interleukin-1 inhibitors anakinraExpand
  • 11